Insider Stock Trading History of Kelly James H


The following table details the trading activities (stock purchases, stock sales, and stock option exercises) reported to the Securities and Exchange Commission (SEC) by insider Kelly James H since year 2005. The trader's CIK number is 1354557. At the time of this reporting, Kelly James H is the Chief Executive Offi of Stem Cell Innovations, Inc. . (stock ticker symbol SCLL.OB). See this page for all insider trading activities at Stem Cell Innovations, Inc. .


Stock purchases, sales, and option exercises reported by insider Kelly James H since 2005.
  Trade Date   Symbol Company Name (Issuer) Trade Type     Shares       Price ($)   Value ($)
2008-01-03 SCLL.OB Stem Cell Innovations, Inc. Sale 400,000 .01 4,000
2007-12-11 SCLL.OB Stem Cell Innovations, Inc. Sale 640,000 .01 8,320
2007-12-12 SCLL.OB Stem Cell Innovations, Inc. Sale 115,000 .01 1,380
2007-12-13 SCLL.OB Stem Cell Innovations, Inc. Sale 200,000 .01 2,400
2008-03-03 SCLL.OB Stem Cell Innovations, Inc. Sale 44,633 .01 580
2007-12-17 SCLL.OB Stem Cell Innovations, Inc. Sale 155,000 .01 1,705
2007-12-18 SCLL.OB Stem Cell Innovations, Inc. Sale 250,000 .01 2,750
2007-12-19 SCLL.OB Stem Cell Innovations, Inc. Sale 180,000 .01 1,979
2007-12-26 SCLL.OB Stem Cell Innovations, Inc. Sale 173,486 .01 1,734
2008-01-02 SCLL.OB Stem Cell Innovations, Inc. Sale 541,881 .01 5,418
2008-02-29 SCLL.OB Stem Cell Innovations, Inc. Sale 8,200,000 .01 90,200

Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Kelly James H (Chief Executive Offi of Stem Cell Innovations, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.